Floxade-OZ Tablet is a potent combination antibiotic containing Ofloxacin 200mg and Ornidazole 500mg, designed to treat a wide range of bacterial and protozoal infections. Ofloxacin, a fluoroquinolone antibiotic, works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial replication and repair, thereby effectively eliminating susceptible bacteria. Ornidazole, a nitroimidazole derivative, targets anaerobic bacteria and protozoa by disrupting their DNA synthesis, making this combination highly effective against mixed infections involving both aerobic and anaerobic organisms. Floxade-OZ is commonly prescribed for infections such as urinary tract infections, gastrointestinal infections including amoebiasis, respiratory tract infections, skin and soft tissue infections, and pelvic inflammatory disease. The dual action of Ofloxacin and Ornidazole ensures broad-spectrum coverage, reducing the risk of resistance and improving treatment outcomes. It is essential to use Floxade-OZ under medical supervision, adhering strictly to the prescribed dosage and duration to prevent resistance development and minimize side effects. Common side effects may include nausea, dizziness, and gastrointestinal discomfort, while serious adverse reactions are rare but require immediate medical attention. This combination therapy offers an effective solution for managing complex infections caused by diverse pathogens.